SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001564590-20-017304
Filing Date
2020-04-17
Accepted
2020-04-17 17:21:59
Documents
3
Period of Report
2020-06-16

Document Format Files

Seq Description Document Type Size
1 PRE 14A 2020 PRELIM PROXY snss-pre14a_20200616.htm PRE 14A 1144896
2 GRAPHIC gtiscuztnxcx000001.jpg GRAPHIC 2227
3 GRAPHIC gtiscuztnxcx000002.jpg GRAPHIC 2227
  Complete submission text file 0001564590-20-017304.txt   1152515
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-51531 | Film No.: 20800610
SIC: 2834 Pharmaceutical Preparations